Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C013813 |
4-anisidine |
4-anisidine results in decreased expression of ELK1 mRNA | decreases expression | 12929121
|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in decreased expression of ELK1 mRNA | decreases expression | 12419474
|
C121465 |
6-methyl-2-(phenylethynyl)pyridine |
6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Dextroamphetamine results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 12377393
|
D003913 |
Dextroamphetamine |
6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Dextroamphetamine results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 12377393
|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in increased phosphorylation of ELK1 protein | increases phosphorylation | 12377393
|
D003913 |
Dextroamphetamine |
N-phenyl-7-(hydroxyimino)cyclopropa(b)chromen-1a-carboxamide inhibits the reaction [Dextroamphetamine results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 12377393
|
D000841 |
Anisomycin |
Anisomycin results in increased phosphorylation of ELK1 protein | increases phosphorylation | 12660819
|
D000841 |
Anisomycin |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Anisomycin results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 12660819
|
D000841 |
Anisomycin |
PD 98059 inhibits the reaction [Anisomycin results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 12660819
|
C432165 |
anthra(1,9-cd)pyrazol-6(2H)-one |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Anisomycin results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 12660819
|
C432165 |
anthra(1,9-cd)pyrazol-6(2H)-one |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Curcumin results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 18316600
|
C432165 |
anthra(1,9-cd)pyrazol-6(2H)-one |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [sodium arsenite results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 12660819
|
C015001 |
arsenite |
arsenite promotes the reaction [ELK1 protein binds to DDIT4 promoter] | affects binding|increases reaction | 16008523
|
C015001 |
arsenite |
arsenite results in increased activity of ELK1 protein | increases activity | 16008523
|
D020148 |
Butyric Acid |
Butyric Acid results in increased activity of ELK1 protein | increases activity | 15103026
|
D020148 |
Butyric Acid |
U 0126 inhibits the reaction [Butyric Acid results in increased activity of ELK1 protein] | decreases reaction|increases activity | 15103026
|
D003024 |
Clozapine |
Clozapine results in decreased phosphorylation of ELK1 protein | decreases phosphorylation | 12871586
|
D003474 |
Curcumin |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Curcumin results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 18316600
|
D003474 |
Curcumin |
Curcumin results in increased phosphorylation of ELK1 protein | increases phosphorylation | 18316600
|
D003474 |
Curcumin |
U 0126 inhibits the reaction [Curcumin results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 18316600
|
D003513 |
Cycloheximide |
Cycloheximide results in increased expression of ELK1 mRNA | increases expression | 19684285
|
D003513 |
Cycloheximide |
[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of ELK1 mRNA | affects cotreatment|increases expression | 19684285
|
C004742 |
daidzein |
daidzein results in increased phosphorylation of and results in increased activity of ELK1 protein | increases activity|increases phosphorylation | 16972265
|
D004958 |
Estradiol |
Estradiol results in increased phosphorylation of and results in increased activity of ELK1 protein | increases activity|increases phosphorylation | 16024245
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ELK1 mRNA | affects cotreatment|increases expression | 17942748
|
C045989 |
eticlopride |
eticlopride results in increased phosphorylation of ELK1 protein | increases phosphorylation | 12871586
|
D006220 |
Haloperidol |
Haloperidol results in increased phosphorylation of ELK1 protein | increases phosphorylation | 12871586
|
D006220 |
Haloperidol |
SL 327 inhibits the reaction [Haloperidol results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 12871586
|
D017313 |
Fenretinide |
PD 98059 inhibits the reaction [Fenretinide results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 16407847
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased expression of ELK1 mRNA | decreases expression | 12419474
|
C067431 |
letrozole |
letrozole results in increased expression of ELK1 protein | increases expression | 15967659
|
C013598 |
methoxyacetic acid |
methoxyacetic acid promotes the reaction [EGF protein results in increased activity of ELK1 protein] | increases activity|increases reaction | 15103026
|
C013598 |
methoxyacetic acid |
methoxyacetic acid results in increased activity of ELK1 protein | increases activity | 15103026
|
C013598 |
methoxyacetic acid |
U 0126 inhibits the reaction [methoxyacetic acid promotes the reaction [EGF protein results in increased activity of ELK1 protein]] | decreases reaction|increases activity|increases reaction | 15103026
|
C013598 |
methoxyacetic acid |
U 0126 inhibits the reaction [methoxyacetic acid results in increased activity of ELK1 protein] | decreases reaction|increases activity | 15103026
|
C442478 |
N-phenyl-7-(hydroxyimino)cyclopropa(b)chromen-1a-carboxamide |
N-phenyl-7-(hydroxyimino)cyclopropa(b)chromen-1a-carboxamide inhibits the reaction [Dextroamphetamine results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 12377393
|
D017239 |
Paclitaxel |
Paclitaxel results in decreased expression of ELK1 mRNA | decreases expression | 12929121
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [Anisomycin results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 12660819
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [Fenretinide results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 16407847
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [sodium arsenite results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 12660819
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [sulindac sulfide results in increased phosphorylation of and results in increased activity of ELK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17599376
|
C093973 |
PD 98059 |
[SB 203580 co-treated with PD 98059] inhibits the reaction [sodium arsenite results in increased phosphorylation of ELK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 12660819
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [Phenylephrine results in increased expression of ELK1 mRNA] | decreases reaction|increases expression | 10900171
|
D010656 |
Phenylephrine |
MAPK1 protein affects the reaction [Phenylephrine results in increased expression of ELK1 mRNA] | affects reaction|increases expression | 10900171
|
D010656 |
Phenylephrine |
MAPK3 protein affects the reaction [Phenylephrine results in increased expression of ELK1 mRNA] | affects reaction|increases expression | 10900171
|
D010656 |
Phenylephrine |
PD 98059 inhibits the reaction [Phenylephrine results in increased expression of ELK1 mRNA] | decreases reaction|increases expression | 10900171
|
D010656 |
Phenylephrine |
Phenylephrine promotes the reaction [ELK1 protein modified form binds to FOS promoter] | affects binding|increases reaction | 10900171
|
D010656 |
Phenylephrine |
Phenylephrine results in increased expression of ELK1 mRNA | increases expression | 10900171
|
D010656 |
Phenylephrine |
Phenylephrine results in increased phosphorylation of ELK1 protein | increases phosphorylation | 10900171
|
C093642 |
SB 203580 |
[SB 203580 co-treated with PD 98059] inhibits the reaction [sodium arsenite results in increased phosphorylation of ELK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 12660819
|
C424127 |
SL 327 |
SL 327 inhibits the reaction [Haloperidol results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 12871586
|
C017947 |
sodium arsenite |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [sodium arsenite results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 12660819
|
C017947 |
sodium arsenite |
PD 98059 inhibits the reaction [sodium arsenite results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 12660819
|
C017947 |
sodium arsenite |
[SB 203580 co-treated with PD 98059] inhibits the reaction [sodium arsenite results in increased phosphorylation of ELK1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 12660819
|
C017947 |
sodium arsenite |
sodium arsenite results in increased activity of ELK1 protein | increases activity | 15292961
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of ELK1 mRNA | increases expression | 12016162
|
C017947 |
sodium arsenite |
sodium arsenite results in increased phosphorylation of ELK1 protein | increases phosphorylation | 12660819
|
C025462 |
sulindac sulfide |
ELK1 protein promotes the reaction [sulindac sulfide results in increased expression of EGR1 mRNA] | increases expression|increases reaction | 17599376
|
C025462 |
sulindac sulfide |
MAPK1 protein promotes the reaction [sulindac sulfide results in increased phosphorylation of and results in increased activity of ELK1 protein] | increases activity|increases phosphorylation|increases reaction | 17599376
|
C025462 |
sulindac sulfide |
MAPK3 protein promotes the reaction [sulindac sulfide results in increased phosphorylation of and results in increased activity of ELK1 protein] | increases activity|increases phosphorylation|increases reaction | 17599376
|
C025462 |
sulindac sulfide |
PD 98059 inhibits the reaction [sulindac sulfide results in increased phosphorylation of and results in increased activity of ELK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17599376
|
C025462 |
sulindac sulfide |
sulindac sulfide results in increased phosphorylation of and affects the activity of ELK1 protein | affects activity|increases phosphorylation | 17599376
|
C025462 |
sulindac sulfide |
U 0126 inhibits the reaction [sulindac sulfide results in increased phosphorylation of and results in increased activity of ELK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17599376
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of ELK1 mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of ELK1 mRNA | affects cotreatment|increases expression | 19684285
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ELK1 mRNA | increases expression | 19684285
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ELK1 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ELK1 mRNA | increases expression | 19684285
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ELK1 mRNA | increases expression | 15897893
|
C012589 |
trichostatin A |
trichostatin A results in increased activity of ELK1 protein | increases activity | 15103026
|
C012589 |
trichostatin A |
U 0126 inhibits the reaction [trichostatin A results in increased activity of ELK1 protein] | decreases reaction|increases activity | 15103026
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [Butyric Acid results in increased activity of ELK1 protein] | decreases reaction|increases activity | 15103026
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [Curcumin results in increased phosphorylation of ELK1 protein] | decreases reaction|increases phosphorylation | 18316600
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [methoxyacetic acid promotes the reaction [EGF protein results in increased activity of ELK1 protein]] | decreases reaction|increases activity|increases reaction | 15103026
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [methoxyacetic acid results in increased activity of ELK1 protein] | decreases reaction|increases activity | 15103026
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [sulindac sulfide results in increased phosphorylation of and results in increased activity of ELK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17599376
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [trichostatin A results in increased activity of ELK1 protein] | decreases reaction|increases activity | 15103026
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [Valproic Acid promotes the reaction [EGF protein results in increased activity of ELK1 protein]] | decreases reaction|increases activity|increases reaction | 15103026
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [Valproic Acid results in increased activity of ELK1 protein] | decreases reaction|increases activity | 15103026
|
D014635 |
Valproic Acid |
U 0126 inhibits the reaction [Valproic Acid promotes the reaction [EGF protein results in increased activity of ELK1 protein]] | decreases reaction|increases activity|increases reaction | 15103026
|
D014635 |
Valproic Acid |
U 0126 inhibits the reaction [Valproic Acid results in increased activity of ELK1 protein] | decreases reaction|increases activity | 15103026
|
D014635 |
Valproic Acid |
Valproic Acid promotes the reaction [EGF protein results in increased activity of ELK1 protein] | increases activity|increases reaction | 15103026
|
D014635 |
Valproic Acid |
Valproic Acid results in increased activity of ELK1 protein | increases activity | 15103026
|
D015032 |
Zinc |
Zinc results in increased phosphorylation of and results in increased activity of ELK1 protein | increases activity|increases phosphorylation | 16960431
|
C016837 |
zinc chloride |
zinc chloride results in increased phosphorylation of and results in increased activity of ELK1 protein | increases activity|increases phosphorylation | 16960431
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
methoxyacetic acid |
12.34 | 1761407 1761404 3652986 15959878 12805644 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
12.34 | 14514962 15322242 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
12.34 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.61 | 19490988 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.58 | 17505938 |
MESH:D000168 |
Acrocephalosyndactylia |
|
U 0126 |
5.13 | 17694057 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
5.05 | 16889938 17190629 17202136 |
MESH:D000230 |
Adenocarcinoma |
|
daidzein |
9.43 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.43 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
9.43 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
9.43 | 10697514 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.34 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.54 | 17306315 16712894 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.71 | 12649775 14617031 16160616 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.72 | 17887948 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
6.31 | 15590663 |
MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
6.31 | 18759972 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
6.31 | 17119284 16410023 16325427 16580781 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.87 | 17688650 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
3.88 | 10965797 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.64 | 11748828 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.56 | 16916123 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.30 | 17497229 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
3.81 | 17460149 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.12 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.45 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
2.65 | 16807698 |
MESH:D001249 |
Asthma |
|
Zinc |
2.84 | 17085522 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
3.11 | 18704882 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.34 | 18080171 19368416 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.34 | 18985861 18775368 18558336 19232924 18316065 19460635 17507914 18396377 20603192 16609825 15238991 18177632 17157402 17688650 18940202 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
4.15 | 19761891 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.89 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.73 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.43 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.26 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.26 | 8888407 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.24 | 15867366 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.19 | 15306635 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
4.34 | 17109824 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
3.98 | 16770732 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
8.15 | 17596214 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
8.15 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
2.79 | 16243823 19250217 18462866 18593918 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.79 | 17289903 18497071 12948864 19861407 14630087 17261762 16675129 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
2.79 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
letrozole |
2.79 | 17892469 16002280 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
2.79 | 15136595 11325840 16273361 18234424 16244791 18223236 16115903 18323546 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.79 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.11 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
7.36 | 18593918 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.36 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
8.23 | 19418558 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
8.23 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
8.23 | 17159502 16270382 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
8.23 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
8.23 | 17306315 16507464 15276417 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
5.50 | 18414057 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
5.50 | 12391285 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
9.96 | 18462866 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
9.96 | 16274795 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
9.96 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
9.96 | 16543248 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
6.22 | 15728586 17287366 17124262 11754973 16170337 11179087 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.22 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
daidzein |
11.00 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
11.00 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
11.00 | 16936243 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
4.56 | 15215559 1977408 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
5.94 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
5.94 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
5.12 | 16154183 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.58 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.87 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.62 | 16919318 17110522 15861022 17681005 11677210 16105132 17333356 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.95 | 15340226 15668235 12621046 16354765 8697196 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.62 | 17123785 |
MESH:D003092 |
Colitis |
|
Curcumin |
3.83 | 16782535 16804969 18200517 |
MESH:D003103 |
Coloboma |
|
Curcumin |
4.23 | 18809619 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
3.82 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
3.82 | 19359593 16340194 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
2.92 | 17273769 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
2.92 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.76 | 17141729 14669216 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
4.55 | 18497527 |
MESH:D019465 |
Craniofacial Abnormalities |
|
6-methyl-2-(phenylethynyl)pyridine |
5.17 | 17065172 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.17 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
5.17 | 16575769 17688650 8888407 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
5.17 | 19302082 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
4.52 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.26 | 11575062 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
3.91 | 16479319 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
9.53 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
9.53 | 18403477 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
daidzein |
9.53 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
9.53 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
8.05 | 18204486 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
8.05 | 19279558 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.19 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.41 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
3.41 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.50 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
3.72 | 17351913 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
3.93 | 16402076 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.72 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.08 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.54 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
2.85 | 12538720 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
5.28 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
daidzein |
7.08 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.08 | 19148513 11473722 18566989 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.72 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.81 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.56 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.75 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.29 | 6426943 6254150 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
3.95 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.71 | 3659116 |
MESH:D007172 |
Erectile Dysfunction |
|
daidzein |
4.68 | 14972507 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
4.63 | 16481741 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
4.63 | 16543248 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.75 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
16.24 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
16.24 | 19297423 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
16.24 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
16.24 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.11 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.53 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.79 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
arsenite |
12.90 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
12.90 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.90 | 20067830 |
MESH:D005532 |
Foot Deformities, Congenital |
|
methoxyacetic acid |
5.38 | 3652986 |
MESH:D005756 |
Gastritis |
|
Zinc |
4.44 | 17241300 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
4.35 | 18462866 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.32 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
10.80 | 17596214 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
10.80 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
10.80 | 18801729 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.23 | 10696789 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
3.73 | 17217573 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
3.42 | 18462866 18829502 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.14 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
Zinc |
3.39 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
5.41 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
4.21 | 17241300 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.02 | 11000095 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
4.34 | 17276780 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.55 | 16120746 15340226 12621046 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.69 | 17701891 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.67 | 15709030 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.39 | 17440010 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.87 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.39 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.51 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.68 | 16354765 8697196 18606429 16959395 15340226 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
3.74 | 18704882 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
4.56 | 16046005 |
MESH:D006973 |
Hypertension |
|
daidzein |
7.99 | 17169123 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
7.99 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.99 | 18850075 18670907 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.24 | 18502941 12791704 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.46 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.14 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
5.86 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
5.86 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Curcumin |
4.47 | 16956363 17151092 18403477 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.47 | 12878042 12200463 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
3.06 | 18596194 18200517 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.74 | 16627594 16393666 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
3.91 | 10783313 |
MESH:D007511 |
Ischemia |
|
Zinc |
4.29 | 16584753 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.02 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
8.99 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
8.99 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
8.99 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
9.17 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
9.17 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
2.70 | 15610895 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
4.25 | 18555241 |
MESH:D007938 |
Leukemia |
|
Curcumin |
3.06 | 18462866 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
3.89 | 16106398 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
17.76 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
PD 98059 |
17.76 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
U 0126 |
17.76 | 16972261 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
3.95 | 18206229 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.95 | 16294345 17596541 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
4.43 | 16106398 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
5.68 | 16707609 |
MESH:D017880 |
Limb Deformities, Congenital |
|
methoxyacetic acid |
4.49 | 12805644 15959878 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
3.71 | 17567588 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.49 | 17353645 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
3.22 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
3.24 | 17355460 18705752 18006644 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.24 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.24 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
2.53 | 16956363 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
3.99 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
3.99 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
1.89 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.94 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.90 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
4.50 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
4.50 | 18462866 19359593 16243823 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
4.50 | 19931552 16712894 15276417 17306315 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.50 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
3.34 | 18462866 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
3.81 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
4.35 | 16173963 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
8.83 | 11807958 16891317 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
8.83 | 10697514 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
8.83 | 12773700 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.12 | 19453300 |
MESH:D008545 |
Melanoma |
|
Curcumin |
9.06 | 17885582 18462866 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
9.06 | 16270382 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
9.06 | 12025231 12040289 16342250 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
9.06 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
9.06 | 16505122 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
3.82 | 17263510 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
7.20 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
7.20 | 16856516 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.12 | 19142101 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.94 | 18803445 18765137 |
MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
5.16 | 1613127 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
4.05 | 16274795 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
10.88 | 19372569 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
10.88 | 14749477 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
10.88 | 18172295 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
4.56 | 17962980 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.71 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
2.95 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.74 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.01 | 16810080 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
4.03 | 18495463 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
3.11 | 15867366 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
4.85 | 15958647 17353921 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.85 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.32 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
4.17 | 12497104 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
8.97 | 15738583 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
8.97 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.35 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.35 | 14600291 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
5.27 | 18462866 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
6.57 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
6.57 | 8888407 16359493 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.32 | 16303764 |
MESH:D009765 |
Obesity |
|
Clozapine |
4.72 | 19142110 18515891 |
MESH:D009765 |
Obesity |
|
Curcumin |
4.72 | 19297423 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.63 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
3.25 | 18719352 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
21.09 | 19020741 18462866 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
21.09 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
21.09 | 16133793 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
21.09 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
21.09 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
21.09 | 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
U 0126 |
21.09 | 16211241 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
8.11 | 17440100 19401701 19196508 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
8.11 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
8.11 | 19294695 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.36 | 11578682 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
3.74 | 12065085 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.89 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
5.14 | 11550810 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.22 | 18163543 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
3.90 | 17114810 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.29 | 11222880 11399792 11896295 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
8.29 | 20603192 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
4.90 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.57 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
2.05 | 18226269 10851300 18156803 18769126 12497104 11398177 15129424 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.05 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
2.05 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
2.05 | 16356831 17136230 17172428 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.05 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
2.05 | 18798265 19789329 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
2.05 | 12429649 16700911 16517595 16606632 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.96 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.18 | 11422049 12752131 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
4.61 | 11575062 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
8.31 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
8.31 | 11575062 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
4.22 | 19168576 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
3.70 | 18379247 10666014 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.50 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
8.51 | 16303925 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
8.51 | 16584753 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.85 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Curcumin |
3.81 | 18462866 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
5.35 | 18806925 20452607 11151749 18855531 16141801 20521326 17667964 20580759 20107430 17726453 20521320 19369910 20168265 17123785 11763009 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
5.35 | 19369910 18513383 1830565 20107430 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
5.35 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.51 | 1511512 15475178 11044598 17978042 3137016 16876388 11738929 14763951 |
MESH:D018805 |
Sepsis |
|
Curcumin |
3.79 | 18389075 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.35 | 7327846 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
12.20 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
12.20 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
12.20 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.20 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.58 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
8.64 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
8.64 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.18 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
2.44 | 18506536 18396642 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
3.19 | 16631530 19188055 |
MESH:D013576 |
Syndactyly |
|
methoxyacetic acid |
5.29 | 1761404 1761407 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
4.37 | 20210726 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.46 | 16930453 |
MESH:D013733 |
Testicular Diseases |
|
methoxyacetic acid |
4.98 | 18486176 6499806 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.29 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.86 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.54 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.32 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
4.09 | 16543248 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.87 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.17 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
7.67 | 18593936 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
7.67 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
7.67 | 11723127 17306315 16452187 16712894 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.30 | 8888407 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
4.91 | 18462866 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
8.72 | 16154183 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
8.72 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
8.57 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
8.57 | 18645019 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.07 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.23 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.22 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.89 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
4.17 | 20564506 20107430 16141801 17502770 20521320 16402076 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
4.72 | 17933447 |